Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 26, 2026
FUTU vs IBKR: Weighing Rapid Asian Growth Against Global Stability

FUTU vs IBKR: Weighing Rapid Asian Growth Against Global Stability

Key Takeaways

  • FUTU (Futu Holdings) is a Hong Kong–headquartered digital brokerage known for its Futubull and Moomoo platforms, with a strong retail presence across Asia.
  • IBKR (Interactive Brokers) is a global automated electronic broker serving retail, institutional, and advisor clients across more than 170 markets.
  • FUTU trades at a much lower valuation (P/E near 11x) than IBKR (P/E roughly 36–41x), reflecting different growth profiles and regulatory risk.
  • IBKR offers broader geographic and product diversification, while FUTU carries meaningful exposure to Mainland China regulatory and compliance risk.
  • Both names have posted strong recent growth, but FUTU's momentum has been punctuated by a one-time regulatory penalty, while IBKR's gains have been steadier.
  • IBKR's scale and consistency may appeal to stability-focused investors, while FUTU offers faster growth and international expansion at a discounted multiple.

Introduction

Investors comparing online brokerages often weigh FUTU and IBKR as two distinct ways to gain exposure to the digitization of global trading. Futu Holdings is a fast-growing Asian brokerage and wealth platform built around the Futubull and Moomoo apps, while Interactive Brokers is a decades-old automated broker with worldwide reach and a diversified, institutional-grade client base. This stock comparison examines how the two companies differ in business model, growth drivers, relative performance, and market positioning. Traders focused on momentum and value may find Futu compelling, whereas investors prioritizing scale, stability, and geographic breadth may gravitate toward Interactive Brokers. Both merit close attention in the current market environment.

FUTU Overview and Recent Performance

Futu Holdings operates digital securities brokerage and wealth-management services, primarily through its Futubull (Hong Kong/China) and Moomoo (international) platforms. The company generates revenue from brokerage commissions, margin financing and securities lending interest, and other services such as IPO distribution and currency exchange. In recent quarters, FUTU has delivered record operational results. Second-quarter 2026 revenue reached approximately HK$7.2 billion, up about 36% year over year, with net income of roughly HK$3.65 billion. Total trading volume hit a record above HK$6 trillion, driven by strong retail interest in U.S. equities tied to artificial intelligence and semiconductors. The company added about 252,000 funded accounts in the quarter to reach 3.84 million, while total client assets climbed roughly 44% year over year. That momentum has been partially offset by regulatory headwinds. In the first quarter of 2026, Futu recorded a large administrative penalty from the China Securities Regulatory Commission (CSRC), which sharply reduced reported net income for that period even as underlying operations stayed strong. Futu has continued expanding internationally, securing a new securities license in Thailand and deepening its presence in Malaysia, Singapore, and Japan. Recent stock behavior has reflected this tension between rapid growth and persistent compliance risk. From what I see, I also checked this using Tickeron’s AI Trend Prediction Engine to gauge the underlying momentum signals.

IBKR Overview and Recent Performance

Interactive Brokers Group is an automated electronic broker and a member of the S&P 500, providing trade execution and custody for stocks, options, futures, foreign exchange, bonds, and funds across more than 170 markets. It serves individual investors, hedge funds, proprietary trading groups, financial advisors, and introducing brokers. IBKR has continued its pattern of steady, broad-based growth in recent quarters. Customer accounts rose to about 5.19 million, up roughly 34% year over year, with client equity near $930 billion. Commission revenue has grown in the high-teens percentages, while net interest income (the spread earned on client cash and margin loans) has also expanded. The firm's automated platform supports an exceptionally high pre-tax margin of around 77%. In the first quarter of 2026, Interactive Brokers reported record net revenues and raised its quarterly dividend, and it has since expanded into crypto trading, prediction markets, and new partnerships such as an X Cashtags integration. IBKR's stock has posted a strong year-to-date advance, though recent weeks have shown some consolidation as the shares trade below their 52-week high. Sentiment remains broadly positive, with a consensus "Buy" rating from analysts.

Head-to-Head Comparison

The two companies occupy different ends of the brokerage spectrum. FUTU is a younger, retail-centric platform concentrated in Hong Kong, Greater China, and select Southeast Asian markets. Its growth is tied to client acquisition, retail trading activity, and new geographic licenses, and its results can swing with shifts in retail risk appetite and regulatory developments. IBKR is a global, multi-asset broker with a more diversified client mix and a balance sheet with no long-term debt, which contributes to more predictable, margin-rich earnings. On valuation, the contrast is stark: FUTU trades near 11x trailing earnings, while IBKR trades at roughly 36–41x. That gap partly reflects IBKR's steadier growth and lower regulatory risk versus FUTU's faster but more volatile trajectory. Growth drivers also differ: FUTU is expanding into new Asian markets and wealth products, while IBKR is monetizing rising client balances and broadening into crypto, prediction markets, and new geographies such as South Korea. From a risk standpoint, FUTU carries concentrated China regulatory exposure, whereas IBKR's main sensitivities are interest rates and a premium earnings multiple.

Tickeron AI Verdict

Based on observable factors, Tickeron's AI would likely lean toward IBKR for its trend consistency, stability, and diversified catalysts. Interactive Brokers combines durable account growth, high margins, a debt-free balance sheet, and steady earnings expansion, which align well with models that favor consistency and lower drawdown risk. FUTU, by contrast, presents a faster-growth, lower-valuation profile but carries more concentrated regulatory and geographic risk that can make its price trend less predictable. The AI would most probably favor IBKR on a stability-adjusted basis, while acknowledging FUTU's stronger growth momentum and cheaper valuation as factors that could support higher returns for investors comfortable with elevated volatility.

Exploring AI Trading Bots for Brokerage Analysis

In my own process, I often review Tickeron’s AI Trading Bots to see how rules-based systems are currently handling names like these amid shifting market conditions. The platform offers a range of strategies with transparent performance data, which helps put the relative momentum of FUTU and IBKR into additional context without replacing fundamental review.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IBKR, FUTU

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IBKR in +5.46% Uptrend, advancing for three consecutive days on September 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IBKR advanced for three days, in 260 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 71 cases where IBKR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.

The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBKR as a result. In 47 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for IBKR turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 27 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

IBKR moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IBKR crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBKR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

IBKR broke above its upper Bollinger Band on August 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IBKR entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. IBKR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.849) is normal, around the industry mean (4.579). P/E Ratio (35.417) is within average values for comparable stocks, (30.282). Projected Growth (PEG Ratio) (1.441) is also within normal values, averaging (0.811). Dividend Yield (0.004) settles around the average of (0.016) among similar stocks. P/S Ratio (3.498) is also within normal values, averaging (16.763).

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 12.93B. The market cap for tickers in the group ranges from 590 to 308.32B. MS holds the highest valuation in this group at 308.32B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 16%. NCPL experienced the highest price growth at 84%, while AXG experienced the biggest fall at -89%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was -49%. For the same stocks of the Industry, the average monthly volume growth was 30% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 63
Price Growth Rating: 56
SMR Rating: 74
Profit Risk Rating: 86
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
IBKR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company through its subsidiaries provides brokerage and investment services

Industry InvestmentBanksBrokers

Industry
Investment Banks Or Brokers
Address
One Pickwick Plaza
Phone
+1 203 618-5800
Employees
3182
Web
https://www.interactivebrokers.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.